Treatments and outcomes of adult patients with TP53-mutated acute myeloid leukemia (AML) in the real-life –Report of the prospective french observational ALFA-PPP study.Jean-Baptiste Micol, Elsa Bernard, Ramy Rahmé et al.|Blood|2025Cited by 1
Real-life CD34+CD38- leukemic stem cell (LSC) flow quantification in adult AML at diagnosis independently predicts survival of intensively but not AZA-VEN treated patients: A study of prospective observational ALFA-PPP acute leukemia french associationAdriana Pleșa, Christophe Roumier, Alexandra Coelho et al.|Blood|2025Cited by 1
Treatments and Outcomes of Adult Patients with AML in the Real-Life - First Report of the French Observational ALFA-PPP StudyHervé Dombret, Stéphane de Botton, Alexandra Coelho et al.|Blood|2024Cited by 0
Real life treatments and outcomes of older patients aged more than 60 years with FLT3-mutated acute myeloid leukemia: Report from the multicentric french observational ALFA-PPP studyRamy Rahmé, Thorsten Braun, Emmanuel Raffoux et al.|Blood|2025Cited by 0